Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 

Background

Holly Chamberlain is an Associate in the Boston office of Fish & Richardson. Ms. Chamberlain’s practice focuses on patent prosecution in a variety of areas including the biomedical, mechanical, and electromechanical arts. She was previously a Summer Associate for the firm in 2015. 

Education

J.D., Boston College Law School 2016
​Editor, Intellectual Property and Technology Forum​


B.S., Massachusetts Institute of Technology 2013
Biological Engineering

Admissions

  • Massachusetts 2016
  • U.S. Patent and Trademark Office 2013

Other Distinctions

Publications

Amgen’s Humira Biosimilar Becomes the Fourth FDA Approved Biosimilar, co-written with Jenny Shmuel and Tasha Francis, Fish Litigation Blog (September 27, 2016).

Amgen Argues “Entire Balance BPCIA” in Jeopardy unless Federal Circuit Overturns Discovery Ruling, co-written with Jenny Shmuel and Tasha Francis, Fish Litigation Blog (September 20, 2016)

Bellan L, Chamberlain H, Wu D, Langer R. (2013). Microfluidic Vascular Networks for Engineered Tissues. In: C. Bettinger, J.T. Borenstein, S.L. Tao (Eds.), Micro and Nano Technologies: Microfluidic cell culture systems (pp. 223-245).

Services

What's trending with Holly